Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Revaprazan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Acid-related diseases (ARDs), such as peptic ulcers and gastroesophageal reflux disease, represent a major health-care concern… Expand
Is this relevant?
2015
2015
Background/Aims Proton pump inhibitors (PPIs) act by irreversibly binding to the H+-K+-ATPase of the proton pump in parietal… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2012
2012
Chronic gastric inflammation developing after Helicobacter pylori (H. pylori) infection is responsible for either dyspeptic… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Background/Aims: Proton pump inhibitors (PPIs) are widely used to prevent nonsteroidal anti-inflammatory drug (NSAID)-induced… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
BACKGROUND To date, no definitive treatment of functional dyspepsia (FD) has been proven to be effective and reasonably well… Expand
  • figure 1
  • table II
  • figure 2
  • table III
  • table IV
Is this relevant?
2010
2010
BACKGROUND AND AIM Revaprazan is a novel acid pump antagonist. The aim of this study was to investigate the inhibitory effect of… Expand
Is this relevant?
2007
2007
The present invention provides a water-soluble polymer, a water-soluble saccharide, a surfactant, or a mixture thereof formulas… Expand
Is this relevant?
2007
2007
Background/Aims: This randomized, double-blind, phase III, multicenter trial was carried out to compare the efficacy and safety… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2007
2007
1. The solid dispersion in which particles revaprazana surface modified water-soluble polymer, a water-soluble saccharide, a… Expand
Is this relevant?
2005
2005
Background/Aims: To assess the comparative efficacy and safety of revaprazan, a novel acid pump antagonist, versus omeprazole in… Expand
Is this relevant?